Jan 26 (Reuters) -
* MODERNA STARTS CLINICAL TRIAL OF BOOSTER SHOT TARGETING OMICRON COVID VARIANT - CNBC Further company coverage:
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
118.3 USD | +2.04% |
|
-0.36% | +18.97% |
Jul. 02 | Moderna, Pfizer-BioNTech COVID-19 Vaccine Patent Legal Battle Gets Mixed UK Ruling | MT |
Jul. 02 | Pfizer-BioNTech, Moderna Set to Appeal Mixed UK Ruling in COVID-19 Vaccine Patent Case | MT |
Jan 26 (Reuters) -
* MODERNA STARTS CLINICAL TRIAL OF BOOSTER SHOT TARGETING OMICRON COVID VARIANT - CNBC Further company coverage:
1st Jan change | Capi. | |
---|---|---|
+18.97% | 45.34B | |
+41.98% | 40.42B | |
-10.06% | 37.92B | |
+31.15% | 31.75B | |
-7.79% | 27.71B | |
+13.32% | 26.52B | |
+43.05% | 13.96B | |
+31.28% | 12.44B | |
-7.41% | 11.26B | |
-15.54% | 10.28B |